Juvenile Diabetes Treatment Exercise 2.22 introduces a study examining the effectiveness of the drug teplizumab at delaying or preventing the onset of juvenile diabetes (also called Type 1 diabetes). The results are shown in the table below. teplizumab 16 (with diabetes) 22 (no diabetes) 38 (total) Control 26 (with diabetes) 12 (no diabetes) 38 (total) 42 (total with diabetes) 34 (total no diabetes) 76 (total) (a) Using p^1 to represent the proportion in the control group who developed diabetes and p^2 to represent the proportion in the teplizumab group who developed diabetes, find the sample difference in proportions, p^1-p^2. Round to three decimal places. (b) Find a 99% confidence interval for the difference in proportions p1-p2. Round to three decimal places. _____to_____ (c) What is the best estimate for the difference in proportions? Round to three decimal places. What is the margin of error for this estimate? Round to three decimal places. (d) Can we be confident, at the 99% level, that the new drug teplizumab is more effective than the control?
Juvenile Diabetes Treatment Exercise 2.22 introduces a study examining the effectiveness of the drug teplizumab at delaying or preventing the onset of juvenile diabetes (also called Type 1 diabetes). The results are shown in the table below. teplizumab 16 (with diabetes) 22 (no diabetes) 38 (total) Control 26 (with diabetes) 12 (no diabetes) 38 (total) 42 (total with diabetes) 34 (total no diabetes) 76 (total) (a) Using p^1 to represent the proportion in the control group who developed diabetes and p^2 to represent the proportion in the teplizumab group who developed diabetes, find the sample difference in proportions, p^1-p^2. Round to three decimal places. (b) Find a 99% confidence interval for the difference in proportions p1-p2. Round to three decimal places. _____to_____ (c) What is the best estimate for the difference in proportions? Round to three decimal places. What is the margin of error for this estimate? Round to three decimal places. (d) Can we be confident, at the 99% level, that the new drug teplizumab is more effective than the control?
MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
Related questions
Question
100%
Juvenile Diabetes Treatment Exercise 2.22 introduces a study examining the effectiveness of the drug teplizumab at delaying or preventing the onset of juvenile diabetes (also called Type 1 diabetes). The results are shown in the table below.
teplizumab 16 (with diabetes) 22 (no diabetes) 38 (total)
Control 26 (with diabetes) 12 (no diabetes) 38 (total)
42 (total with diabetes) 34 (total no diabetes) 76 (total)
(a) Using p^1 to represent the proportion in the control group who developed diabetes and p^2 to represent the proportion in the teplizumab group who developed diabetes, find the sample difference in proportions, p^1-p^2. Round to three decimal places.
(b) Find a 99% confidence interval for the difference in proportions p1-p2. Round to three decimal places.
_____to_____
_____to_____
(c) What is the best estimate for the difference in proportions? Round to three decimal places.
What is the margin of error for this estimate? Round to three decimal places.
What is the margin of error for this estimate? Round to three decimal places.
(d) Can we be confident, at the 99% level, that the new drug teplizumab is more effective than the control?
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 3 steps with 3 images
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.Recommended textbooks for you
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman